GLP-1 drugs could become personalized for individuals, study says

Дата публикации: 31-07-2026 10:44:50

The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Different GLP-1 therapies could be tailored to patients' individual metabolic needs	0	7.25	27-07-2026
2	Descubren dos variantes genéticas clave para el éxito de los fármacos para adelgazar como Ozempic o Mounjaro	0	7.07	08-04-2026
3	Most obesity drugs do not improve quality of life or heart health, analysis indicates	-2	7	08-07-2026
4	GLP-1 drugs could reduce long-term sick leave: Study	0	18.9	26-07-2026
5	GLP-1 drugs could reduce long-term sick leave: Study	0	18.9	26-07-2026
6	GLP-1 'secret shopper' study finds gaps in online prescribing	0	5	07-07-2026
7	Women more often hired after losing weight on GLP-1s: Study	0	5	03-07-2026
8	GLP-1 use hits record high as Medicare opens access to weight-loss drugs	0	7	09-07-2026
9	The new GLP-1 generation: From daily tablets to new blockbuster fat jabs, these are the obesity medications that could soon be coming to the UK... and they're more affordable than Mounjaro	0	6.62	20-06-2026
10	After weight loss, exercise beats weight-loss drugs for heart health	0	9.66	21-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.17. Источник: thehill.com.